Free Newsletter
Caliber opens new TX manufacturing facility
Caliber Biotherapeutics has opened the world's largest plant-made pharmaceutical manufacturing facility in its base, Bryan, TX. The company is also planning to develop cell- and microbial-based production systems to enhance its cancer and infectious disease pipeline. The new plant can produce up to 100 million vaccine doses and hundreds of thousands of protein biotherapeutics per month.
"The Caliber platform is designed to be uniquely agile and responsive, enabling us to accelerate development of products with improved efficacy, reduced cost and enhanced safety," said Dr. Brett Giroir, Chief Medical Officer, in a release. "Our goal is to make a rapid, meaningful impact on patients with unmet medical needs, both in the United States as well as in lesser developed countries with profound public health challenges."
- see the Caliber release
Comments
Post a comment
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: